We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Catco Reinsurance Opportunities Fund Limited | LSE:CAT | London | Ordinary Share | BMG1961Q3242 | ORD USD0.00013716 (DI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 25.00 | 14.00 | 36.00 | 25.00 | 25.00 | 25.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Unit Inv Tr, Closed-end Mgmt | 6.33M | 5.44M | 3.6440 | 6.86 | 37.33M |
RNS Number:3429X Cambridge Antibody Tech Group PLC 05 April 2004 SCHEDULE 5 BLOCKLISTING SIX MONTHLY RETURN 1. Name of company Cambridge Antibody Technology 2. Name of scheme Company Share Option Plan 3. Period of return: From 1 October 2003 to 31 March 2004 4. Number and class of shares(s) (amount of stock/debt security) not issued under scheme 226,256 5. Number of shares issued/allotted under scheme during period 97,196 6. Balance under scheme not yet issued/allotted at end of period 129,060 7. Number and class of share(s) (amount of stock/debt securities) originally listed and the date of admission Please confirm total number of shares in issue at the end of the period in order for us to update our records 41,077,807 Contact for queries: Name: Justin Hoskins Address: Cambridge Antibody Technology Milstein Building Granta Park Cambridge CB1 6GH Telephone: 01223 471 471 This information is provided by RNS The company news service from the London Stock Exchange END BLRBELFBZZBLBBV
1 Year Catco Reinsurance Opport... Chart |
1 Month Catco Reinsurance Opport... Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions